Envoy Medical - Class A (COCH) closed at $6.70 on November 20, 2026, unchanged from the previous close, on volume of 25,291 shares (30-day average 76,107).
Data as of November 20, 2026.
Newsfile (Tue, 17-Nov 9:15 AM ET)
Envoy Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
Newsfile (Tue, 10-Nov 8:30 AM ET)
Globe Newswire (Mon, 9-Nov 7:00 AM ET)
Envoy Medical Reports Third Quarter 2026 Results and Highlights Continued Progress
Newsfile (Thu, 5-Nov 7:02 AM ET)
Newsfile (Wed, 28-Oct 8:31 AM ET)
Envoy Medical to Report Third Quarter 2026 Financial Results on Thursday, November 5th
Newsfile (Tue, 27-Oct 8:31 AM ET)
Envoy Medical Announces Reverse Stock Split
Newsfile (Thu, 22-Oct 8:31 AM ET)
Newsfile (Tue, 20-Oct 8:31 AM ET)
Newsfile (Mon, 12-Oct 8:30 AM ET)
Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
Newsfile (Tue, 22-Sep 8:30 AM ET)
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Envoy Medical - Class A trades on the NASDAQ stock market under the symbol COCH.
As of November 20, 2026, COCH stock price was flat at $6.70 with 25,291 million shares trading.
COCH has a beta of 0.63, meaning it tends to be less sensitive to market movements. COCH has a correlation of 0.01 to the broad based SPY ETF.
COCH has a market cap of $51.85 million. This is considered a Micro Cap stock.
Last quarter Envoy Medical - Class A reported $66,000 in Revenue and -$.50 earnings per share. This fell short of revenue expectation by $-14,000 and exceeded earnings estimates by $.18.
In the last 3 years, COCH traded as high as $114.60 and as low as $3.63.
The top ETF exchange traded funds that COCH belongs to (by Net Assets): VXF, VTI.
COCH has underperformed the market in the last year with a return of -5.7%, while SPY returned +5.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in COCH shares. However, COCH has outperformed the market in the last 3 month and 2 week periods, returning -9.5% and -5.6%, while SPY returned -10.1% and -5.9%, respectively. This indicates COCH has been having a stronger performance recently.
COCH support price is $6.21 and resistance is $7.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that COCH shares will trade within this expected range on the day.